Pediatric rheumatology

Treat-to-target achievement and predictive analysis in childhood-onset systemic lupus erythematosus

Rheumatology (Oxford)Published Retrospective cohort study

Authors' conclusion

This single-centre study demonstrates that cLLDAS and cCR are achievable targets in real-life clinical practice. However, maintaining stability in both states remains highly challenging.

Study context

Population
Untreated patients with childhood-onset SLE (cSLE), Wuhan Children's Hospitalmedian follow-up 2.6 years
Participants
97 patients
Outcome
Achievement of treat-to-target (LLDAS, cLLDAS, DORIS remission, childhood-onset clinical remission)
Methodological detailsretrospective application to prospectively gathered data, real-world cohort, single-centre
  • Retrospective application to prospectively gathered data
  • Real-world cohort
  • Single-centre

Main finding

As reported in the abstract

Achievement of treat-to-target (T2T) targets · median follow-up 2.6 years
Lupus low disease activity state (LLDAS) achieved
75 (77.32%)
cLLDAS achieved
70/97 (72.16%)
Definitions of Remission in SLE (DORIS) achieved
64/90 (65.98%)
cCR achieved
41/97 (42.27%)
Median time to LLDAS (years)
1.22
Median time to cLLDAS (years)
1.44
Median time to DORIS (years)
1.49
Median time to cCR (years)
1.52

Observational data: associations, not effects.

Further findings

Maintained state for over half of follow-up (−50)

LLDAS-50
40.21%
cLLDAS-50
30.93%
DORIS-50
23.71%
cCR-50
19.59%

Predictors of target achievement

Male patients achieved cLLDAS and DORIS earlier
Longer disease duration at initial diagnosis was a positive factor for achieving cLLDAS and cCR
Glucocorticoid (GC) pulse therapy was a negative predictor for time to cLLDAS and DORIS
Earlier first cLLDAS or cCR associated with higher probability of cLLDAS-50 and cCR-50

Original publication

Treat-to-target achievement and predictive analysis in childhood-onset systemic lupus erythematosus. Rheumatology (Oxford). Published 25 November 2025. doi:10.1093/rheumatology/keaf620

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.